Year |
Citation |
Score |
2015 |
Decker AM, Witten S, Barann M, Urban BW. Fast and slow interactions of n-alkanols with human 5-HT3A receptors: Implications for anesthetic mechanisms. Biochimica Et Biophysica Acta. 1848: 1524-35. PMID 25863270 DOI: 10.1016/j.bbamem.2015.03.032 |
0.596 |
|
2015 |
Barann M, Stamer UM, Lyutenska M, Stüber F, Bönisch H, Urban B. Effects of opioids on human serotonin transporters. Naunyn-Schmiedeberg's Archives of Pharmacology. 388: 43-9. PMID 25332055 DOI: 10.1007/s00210-014-1056-3 |
0.714 |
|
2013 |
Meiboom MF, Barann M, Witten S, Groeneveld K, Urban BW. Which agonist properties are important for the activation of 5-HT3A receptors? Biochimica Et Biophysica Acta. 1828: 2564-73. PMID 23792067 DOI: 10.1016/j.bbamem.2013.06.013 |
0.795 |
|
2009 |
Combrink S, Kostanian A, Walstab J, Barann M, Brüss M, Göthert M, Bönisch H. Characterization of the naturally occurring Arg344His variant of the human 5-HT 3A receptor. Pharmacological Reports : Pr. 61: 785-97. PMID 19904001 DOI: 10.1016/S1734-1140(09)70134-3 |
0.583 |
|
2009 |
Walkembach J, Brüss M, Urban BW, Barann M. Interactions of metoclopramide and ergotamine with human 5-HT3A receptors and human 5-HT reuptake carriers: Corrigendum British Journal of Pharmacology. 146: 1156-1156. DOI: 10.1038/Sj.Bjp.0706610 |
0.713 |
|
2008 |
Wittmann M, Schaaf T, Peters I, Wirz S, Urban BW, Barann M. The effects of fentanyl-like opioids and hydromorphone on human 5-HT3A receptors. Anesthesia and Analgesia. 107: 107-12. PMID 18635474 DOI: 10.1213/ane.0b013e31817342c2 |
0.718 |
|
2008 |
Barann M, Linden I, Witten S, Urban BW. Molecular actions of propofol on human 5-HT3A receptors: enhancement as well as inhibition by closely related phenol derivatives. Anesthesia and Analgesia. 106: 846-57, table of con. PMID 18292429 DOI: 10.1213/ane.0b013e318162ca7c |
0.774 |
|
2006 |
Wittmann M, Peters I, Schaaf T, Wartenberg HC, Wirz S, Nadstawek J, Urban BW, Barann M. The effects of morphine on human 5-HT3A receptors. Anesthesia and Analgesia. 103: 747-52. PMID 16931691 DOI: 10.1213/01.ane.0000229706.84471.4d |
0.748 |
|
2006 |
Urban BW, Bleckwenn M, Barann M. Interactions of anesthetics with their targets: non-specific, specific or both? Pharmacology & Therapeutics. 111: 729-70. PMID 16483665 DOI: 10.1016/j.pharmthera.2005.12.005 |
0.556 |
|
2006 |
Barann M, Urban B, Stamer U, Dorner Z, Bönisch H, Brüss M. Effects of tramadol and O-demethyl-tramadol on human 5-HT reuptake carriers and human 5-HT3A receptors: a possible mechanism for tramadol-induced early emesis. European Journal of Pharmacology. 531: 54-8. PMID 16427041 DOI: 10.1016/j.ejphar.2005.11.054 |
0.727 |
|
2005 |
Walkembach J, Brüss M, Urban BW, Barann M. Interactions of metoclopramide and ergotamine with human 5-HT(3A) receptors and human 5-HT reuptake carriers. British Journal of Pharmacology. 146: 543-52. PMID 16041395 DOI: 10.1038/sj.bjp.0706351 |
0.755 |
|
2005 |
Walkembach J, Brüss M, Urban BW, Barann M. Kinetics of metoclopramide effects on human 5-HT3A receptors International Congress Series. 1283: 49-54. DOI: 10.1016/j.ics.2005.08.006 |
0.622 |
|
2004 |
Kurzwelly D, Barann M, Kostanian A, Combrink S, Bönisch H, Göthert M, Brüss M. Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor. Pharmacogenetics. 14: 165-72. PMID 15167704 DOI: 10.1097/00008571-200403000-00004 |
0.578 |
|
2004 |
Barann M, Schmidt K, Göthert M, Urban BW, Bönisch H. Influence of sodium substitutes on 5-HT-mediated effects at mouse 5-HT3 receptors. British Journal of Pharmacology. 142: 501-8. PMID 15148263 DOI: 10.1038/sj.bjp.0705788 |
0.749 |
|
2002 |
Barann M, Molderings G, Brüss M, Bönisch H, Urban BW, Göthert M. Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site. British Journal of Pharmacology. 137: 589-96. PMID 12381672 DOI: 10.1038/sj.bjp.0704829 |
0.735 |
|
2002 |
Wittmann M, Nadstawek J, Wartenberg HC, Wirz S, Urban BW, Barann M. Is the emetic affect of opioids mediated via 5-HT3 receptor? | Wird der emetische effekt von opioiden über 5-HT3 ht3-rezeptoren vermittelt? Journal Fur Anasthesie Und Intensivbehandlung. 9: 220-221. |
0.707 |
|
2001 |
Wenningmann I, Barann M, Vidal AM, Dilger JP. The Effects of isoflurane on acetylcholine receptor channels: 3. Effects of conservative polar-to-nonpolar mutations within the channel pore. Molecular Pharmacology. 60: 584-94. PMID 11502891 |
0.713 |
|
2000 |
Brüss M, Barann M, Hayer-Zillgen M, Eucker T, Göthert M, Bönisch H. Modified 5-HT3A receptor function by co-expression of alternatively spliced human 5-HT3A receptor isoforms. Naunyn-Schmiedeberg's Archives of Pharmacology. 362: 392-401. PMID 11111833 DOI: 10.1007/s002100000342 |
0.55 |
|
2000 |
Barann M, Meder W, Dorner Z, Brüss M, Bönisch H, Göthert M, Urban BW. Recombinant human 5-HT3A receptors in outside-out patches of HEK 293 cells: basic properties and barbiturate effects. Naunyn-Schmiedeberg's Archives of Pharmacology. 362: 255-65. PMID 10997728 DOI: 10.1007/s002100000288 |
0.771 |
|
2000 |
Barann M, Friederich P, Retzmann K, Dybek A, Urban BW. Loss of propofol during in vitro experiments. Anesthesiology. 93: 310-1. PMID 10861191 DOI: 10.1097/00000542-200007000-00067 |
0.529 |
|
2000 |
Barann M, Dilger JP, Bönisch H, Göthert M, Dybek A, Urban BW. Inhibition of 5-HT3 receptors by propofol: equilibrium and kinetic measurements. Neuropharmacology. 39: 1064-74. PMID 10727717 DOI: 10.1016/S0028-3908(99)00205-1 |
0.797 |
|
1999 |
Barann M, Göthert M, Brüss M, Bönisch H. Inhibition by steroids of [14C]-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells. Naunyn-Schmiedeberg's Archives of Pharmacology. 360: 234-41. PMID 10543423 DOI: 10.1007/s002109900089 |
0.583 |
|
1998 |
Barann M, Wenningmann I, Dilger JP. Interactions of general anesthetics within the pore of an ion channel. Toxicology Letters. 100: 155-61. PMID 10049136 DOI: 10.1016/S0378-4274(98)00180-5 |
0.71 |
|
1998 |
Barann M, Bönisch H, Urban BW, Göthert M. Inhibition by propofol of 5-HT3 receptors in excised patches of NIE-115 cells. Annals of the New York Academy of Sciences. 861: 278-9. PMID 9928289 DOI: 10.1111/j.1749-6632.1998.tb10223.x |
0.744 |
|
1998 |
Barann M, Bönisch H, Urban BW, Göthert M. Inhibition of 5-HT3 receptor cation channels by ifenprodil in excised patches of N1E-115 cells. Naunyn-Schmiedeberg's Archives of Pharmacology. 358: 145-52. PMID 9749998 DOI: 10.1007/Pl00005236 |
0.768 |
|
1997 |
Barann M, Göthert M, Bönisch H, Dybek A, Urban BW. 5-HT3 receptors in outside-out patches of N1E-115 neuroblastoma cells: basic properties and effects of pentobarbital. Neuropharmacology. 36: 655-64. PMID 9225291 DOI: 10.1016/S0028-3908(97)00059-2 |
0.765 |
|
1997 |
Dilger JP, Boguslavsky R, Barann M, Katz T, Vidal AM. Mechanisms of barbiturate inhibition of acetylcholine receptor channels. The Journal of General Physiology. 109: 401-14. PMID 9089445 DOI: 10.1085/jgp.109.3.401 |
0.762 |
|
1995 |
Göthert M, Hamon M, Barann M, Bönisch H, Gozlan H, Laguzzi R, Metzenauer P, Nickel B, Szelenyi I. 5-HT3 receptor antagonism by anpirtoline, a mixed 5-HT1 receptor agonist/5-HT3 receptor antagonist. British Journal of Pharmacology. 114: 269-74. PMID 7881726 DOI: 10.1111/J.1476-5381.1995.Tb13222.X |
0.625 |
|
1995 |
Barann M, Ruppert K, Göthert M, Bönisch H. Increasing effect of ethanol on 5-HT3 receptor-mediated 14C-guanidinium influx in N1E-115 neuroblastoma cells. Naunyn-Schmiedeberg's Archives of Pharmacology. 352: 149-56. PMID 7477437 DOI: 10.1007/BF00176768 |
0.537 |
|
1993 |
Barann M, Göthert M, Fink K, Bönisch H. Inhibition by anaesthetics of 14C-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells. Naunyn-Schmiedeberg's Archives of Pharmacology. 347: 125-32. PMID 7682657 DOI: 10.1007/BF00169256 |
0.543 |
|
1993 |
Bönisch H, Barann M, Graupner J, Göthert M. Characterization of 5-HT3 receptors of N1E-115 neuroblastoma cells by use of the influx of the organic cation [14C]-guanidinium. British Journal of Pharmacology. 108: 436-42. PMID 7680594 DOI: 10.1111/J.1476-5381.1993.Tb12822.X |
0.605 |
|
Show low-probability matches. |